Novo Nordisk/ US6701002056 /
2024-07-29 10:10:00 PM | Chg. +1.32 | Volume | Bid12:39:25 AM | Ask12:39:25 AM | Market Capitalization | Dividend Y. | P/E Ratio |
---|---|---|---|---|---|---|---|
128.05USD | +1.04% | 3.09 mill. Turnover: 277.2 mill. |
128.18Bid Size: 100 | 128.30Ask Size: 400 | 355.16 bill.USD | - | - |
Fundamentals
FY 2022 | Growth (1Y) | |
---|---|---|
Per Share | ||
Earnings per Share: | 12.26 DKK | 17.89% |
EPS Diluted: | - DKK | - |
Revenues per Share: | - DKK | - |
Book Value per Share: | - DKK | - |
Cash Flow per Share: | - DKK | - |
Dividend per Share: | - DKK | - |
Total | in mill. | |
Revenues: | 176,954.00 DKK | 25.68% |
Net Income: | 55,525.00 DKK | 16.27% |
Operating Cash Flow: | 78,887.00 DKK | - |
Cash and Cash Equivalents: | 12,653.00 DKK | - |
Valuation Ratios
Current | Latest FY* | |
---|---|---|
P/E Ratio: | - | - |
P/S Ratio: | - | - |
P/BV ratio: | - | - |
P/CF Ratio: | - | - |
PEG: | - | - |
Earnings Yield: | - | - |
Dividend Yield: | - | - |
Market Capitalization | ||
Market Capitalization: | 355.16 bill. USD | 235.37 bill. USD |
Free Float Market Cap.: | - USD | - USD |
Market Cap. / Employee: | - USD | - USD |
Shares Outstanding: | - |
Profitability
Gross Profit Margin: | 83.92% |
EBIT Margin: | 42.28% |
Net Profit Margin: | 31.38% |
Return on Equity: | 66.51% |
Return on Assets: | 23.01% |
Financial Strength
Liquidity I / Cash Ratio: | 10.46% |
Liquidity II / Quick Ratio: | 52.27% |
Liquidity III / Current Ratio: | 89.46% |
Debt / Equity Ratio: | 188.98% |
Dynam. Debt / Equity Ratio: | 200.00% |
Efficiency
Employees: | 55,185 |
Personal Expenses / Employee: | - DKK |
Revenues / Employee: | 3,206,559.75 DKK |
Net Income / Employee: | 1,006,161.09 DKK |
Total Assets / Employee: | 4,371,785.81 DKK |
* Fiscal Year End: | 2022-12-31 |
Accounting Standard: | IFRS |
Currency: | DKK |